Updated:
Regal Healthcare Capital Partners
Regal Healthcare Capital Partners is a New York-based healthcare private equity firm focused exclusively on investments in healthcare services companies.
Regal Healthcare Capital Partners
Regal Healthcare Capital Partners is a New York-based healthcare private equity firm focused exclusively on investments in healthcare services companies. It provides healthcare entrepreneurs with the strategic, financial, and operational value-add of deeply specialized growth partners. The firm targets companies with revenue of $20-100M and EBITDA of $2-10M, with typical equity investments of $30-70M.
General information
Firm type
Private Equity
Year founded
2018
Location
Region
North America
Country
United States
City
New York
Corporate office
One Penn Plaza, Suite 4610, New York, NY 10119, United States
Principals
David Kim
Co-Founder and General Partner
Jon Santemma
Co-Founder and General Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Regal Healthcare Capital Partners?
Investment decisions are made by Co-Founders and General Partners Dr. David Kim and Jon Santemma. Kim is a board-certified emergency physician and serial healthcare entrepreneur who co-founded CityMD, Dental365, and Progressive Emergency Physicians; Santemma was Global Head of Healthcare Investment Banking at Jefferies from 2009 to 2018 and previously ran healthcare services coverage at UBS.
How does Regal source proprietary deal flow?
Regal's sourcing model leans on the clinical and entrepreneurial networks of its physician-operator co-founder. With three prior exits as a founder and an active role on the attending staff at Northwell Health, Kim accesses a pipeline of physician-led, multi-site businesses that sit below the radar of larger healthcare private equity platforms.
Does Regal participate in fund commitments or only direct deals?
The firm's public materials describe direct control growth equity and buyout investments. No information on fund-of-fund commitments or LP allocations to external managers has been disclosed.
Which sectors does Regal explicitly avoid?
Regal concentrates exclusively on healthcare services and has not disclosed investments outside that vertical. The website identifies no exposure to medical devices, biopharma, health-tech SaaS, or non-healthcare sectors.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: